Amylyx Pharmaceuticals, Inc 10-Q for FY2022 Q2
Amylyx Pharmaceuticals, Inc. (AMLX)
10-Q
2022-08-11
For: 2022-06-30
View Original
Added on
April 11, 2026
About this 10-Q
Amylyx Pharmaceuticals, Inc filed this 10-Q on August 11, 2022, covering the quarter ended June 30, 2022 (FY2022 Q2).
Headline figures
Quarter ended June 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $54.07M
- compared with a net loss of $21.92M a year earlier
- Diluted EPS
- -$0.93
- compared with -$3.41 a year earlier